Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Eni (E) Withdraws Share Repurchase Plan Amid Crude Oil Plunge

Published 03/18/2020, 10:40 PM
Updated 07/09/2023, 06:31 AM

In the wake of a weak crude pricing scenario, Eni SpA (NYSE:E) announced its decision to take back its plan of authorizing €400 million stock repurchases in 2020.

With oil price now in the bearish territory since the coronavirus pandemic is hurting global energy demand, the outlook for exploration and production business seems gloomy. Thus, upstream energy players are restricting their operational activities and thereby reducing capital budget. Eni — an integrated energy player with huge upstream business — will also be considering to slash its capital budget and anticipated cost levels to cope with the weak crude pricing scenario. Other energy firms that followed suit are Cimarex Energy Co. (NYSE:E) , Pioneer Natural Resources Company (NYSE:PXD) and EOG Resources Inc. (NYSE:EOG) .

Eni added that it will reconsider the stock buy-back program once the Brent crude price recovers to at least $60 per barrel.

Importantly, the integrated energy player has lowered its forecast for Brent crude for 2020 and 2021 to $40-$45 per barrel and $50-$55 per barrel, respectively. In view of the downward revision in commodity prices, the company has decided to review its business plan for 2020-2021.

Headquartered in headquartered in Rome, Italy, Eni currently carries a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Pioneer Natural Resources Company (PXD): Free Stock Analysis Report

EOG Resources, Inc. (EOG): Free Stock Analysis Report

Eni SpA (E): Free Stock Analysis Report

Cimarex Energy Co (XEC): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.